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Abstract
Leveraging health administrative data (HAD) datasets for predicting the risk of chronic
diseases including diabetes has gained a lot of attention in the machine learning community
recently. In this paper, we use the largest health records datasets of patients in Ontario,
Canada. Provided by the Institute of Clinical Evaluative Sciences (ICES), this database is
age, gender and ethnicity-diverse. The datasets include demographics, lab measurements,
drug benefits, healthcare system interactions, ambulatory and hospitalizations records. We
perform one of the first large-scale machine learning studies with this data to study the
task of predicting diabetes in a range of 1 − 10 years ahead, which requires no additional
screening of individuals.
In the best setup, we reach a test AUC of 80.3 with a single-model trained on an
observation window of 5 years with a one-year buffer using all datasets. A subset of
top 15 features alone (out of a total of 963) could provide a test AUC of 79.1. In this
paper, we provide extensive machine learning model performance and feature contribution
analysis, which enables us to narrow down to the most important features useful for diabetes
forecasting. Examples include chronic conditions such as asthma and hypertension, lab
results, diagnostic codes in insurance claims, age and geographical information.
1. Introduction
Preventable chronic conditions such as heart diseases, stroke, cancer and type 2 diabetes
mellitus (T2DM) are the main causes of morbidity and mortality as of 2019 (Ding et al.,
2018; Wu et al., 2018; Bhardwaj et al., 2018). In 2014, in the United States, 7 out of 10 top
causes of mortality were chronic diseases. Chronic diseases formed 86% of the US health
care expenditures in 2010 and costed $345 billion for diabetes and pre-diabetes alone in
2012 (Bhardwaj et al., 2018).
As a long-lasting chronic disease, diabetes occurs due to pancreas failure in producing
insulin, which controls the blood sugar level ; or when the body is inefficient in using the
existing insulin (Samer El Jerjawi and Abu-Naser, 2018). Late diagnosis of diabetes could
result in increased macro-vascular and capillaries difficulties risk, kidney failure, etc that
might increase the healthcare cost (Rosella et al., 2016) and/or even threaten the life of the
patient (Choi et al., 2019). Hence, early prediction of diabetes is of utmost value.
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ar
X
iv
:1
90
4.
04
13
7v
1 
 [s
tat
.A
P]
  8
 A
pr
 20
19
Diabetes Forecasting
The availability of clinical big data opens up a lot of opportunities to revolutionize
healthcare with the use of machine learning techniques (Osmani et al., 2018). Machine
learning experts can help clinicians understand how, when and what data is desired to solve
their problems (Joyce Lee, 2018). It has been demonstrated in several literature works that
machine learning techniques applied to large health administrative datasets can benefit the
areas of risk prediction, hospital readmission reduction, treatment guidance, cost reduction,
etc. (Bhardwaj et al., 2018; Mikalsen, 2019; Thesmar et al., 2019; Garske, 2018; Miotto et al.,
2016). Moreover, they have been proved useful in management of chronic diseases such as
diabetes mellitus and could help mitigate the disease burden (Bhardwaj et al., 2018).
Machine learning techniques can be used in two different setups for chronic diseases
prediction. In the first setup (Alhassan et al., 2018; Zou et al., 2018), individuals are
classified as currently being with or without diabetes. In the second setup, the task is
forward prediction: predicting whether patients will get diabetes or not in the future (Choi
et al., 2019; Razavian et al., 2015b). In this work, we tackle this latter task.
A number of demographic (fixed) features are useful in predicting diabetes. For example,
age and gender have been utilized in a lot of literature works (Samer El Jerjawi and Abu-
Naser, 2018; Razavian et al., 2015b). In this work, we use (among others) country of origin
(Rosella et al., 2012) and geographical information such as latitude and longitude.
As demonstrated in a number of literature works (Razavian et al., 2015a; Nagata et al.,
2018), health insurance claims with diagnostic codes in an International Classification of
Diseases (ICD) format could contain a significant signal for anticipating diabetes. Despite
the sparsity associated with such data, we found these claims to strongly help diabetes
prediction, especially when linked with other immune diseases or hypertension.
Lab test data obtained from health checkups or tests conducted at hospitals also play
a significant role in our diabetes prediction (Nagata et al., 2018). For instance, HbA1c (or
A1c for short) is proven to be useful in predicting type 2 in different common scenarios and
in diagnosing individuals with elevated T2D risk in both the short and long term (Leong
et al., 2018). We will showcase its contribution to the task of diabetes prediction further.
The single-payer healthcare system in Canada, similarly to UK and a few other countries
provides a unified collection of HAD records for all residents and that makes the Institute
for Clinical Evaluative Sciences (ICES) collection of datasets extremely valuable for related
healthcare studies. Moreover, ICES is quite diverse in terms of gender (53-47 male-female
ratio in our cohort), age (year of birth from the 1890s to 2010s) and country of birth (more
than 100).
In this work, we perform diabetes mellitus (type I and II combined) onset prediction
using raw features from a total of 20 datasets obtained from ICES recorded in Ontario,
Canada for 146,371 individuals. Among them, 78,021 individuals have been diagnosed
with diabetes between 2008 and 2018. Each dataset corresponds to a different source
of data, including: lab results (OLIS), insurance claims (OHIP), drug benefits (ODB),
hospitalizations (DAD), ambulatory usage (NACRS) and emergency claims (ERCLAIM).
We use these features as inputs to five different machine learning models (i.e. XGBoost
(Chen and Guestrin, 2016), Highway networks (Srivastava et al., 2015), regularized logistic
regression (LR) (Razavian et al., 2015b), CNN-LSTM (Tonekaboni et al., 2018) and LSTM
sequence to sequence (LSTM-Seq2Seq) (Sutskever et al., 2014)) to predict diabetes onset
using a variable length window of temporal data.
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Technical Significance To the best of our knowledge, we propose the first comprehensive
large-scale machine learning study on relevant datasets from ICES collection in Ontario to
solve the diabetes prediction problem. In fact, we provide: a data pipeline that efficiently
aggregates sparse temporal data from multiple tables with different sizes into a unique
sparse representation vector, a fair comparison of five models of different natures, multiple
metrics for performance evaluation, and finally an exhaustive feature selection/contribution
analysis, that investigates features’ contribution to the prediction of diabetes. The latter
is often of lesser interest in performance-focused studies; versus in this paper, we aim to
interpret all the top features in depth.
Clinical Relevance Our model predictions can be used as a risk score for evaluating
future onset of diabetes. We believe that our prediction model could be deployed to better
understand the distribution of diabetes (and its main contributing features) in the popu-
lation. Our method does not require additional screening cost as it simply looks at all the
historical health data available.
By adopting an extensive set of input features and investigating their contribution, we
attempt to reverse engineer feature selection and give a machine learning model point of
view on which features should be used in priority. This feature contribution-based method
can be used in recommending policies in health planning and strategies to prevent the onset
of diabetes among those at high risks. Our feature contribution analysis suggests that other
chronic diseases such as asthma are linked with future diabetes. It also demonstrates the
importance of lab testing results in diabetes prediction. Finally, by varying the buffer size
(see study design), we show how far in advance we can forecast diabetes with a reasonable
accuracy.
1.1. Related work
Generally, we found two categories of works based on the machine learning problems they
define for prediction of diabetes: current time (diagnosis, classification) (Zou et al., 2018; Wu
et al., 2018; Alhassan et al., 2018) and forward prediction (Choi et al., 2019; Nagata et al.,
2018; Razavian et al., 2015b; Krishnan et al., 2013). As we are interested in predicting the
diabetes incidence in advance (latter problem), we review the relevant forward prediction
work here.
Considering the diabetes-related features used in literature works, we observed two
main approaches. In the first approach, a few important features are selected or engineered
manually/systematically and are used for diabetes prediction or diagnosis (Samer El Jerjawi
and Abu-Naser, 2018; Alhassan et al., 2018). In the second category, all available features
are inputted to a machine (or deep) learning model (Razavian et al., 2015b; Krishnan et al.,
2013) and it is the model’s responsibility to realize the important features (Razavian et al.,
2015b). In this paper, we adopt the second approach.
One of the most relevant literature works is presented in Razavian et al. (2015b). The
authors propose a data-driven model for predicting type 2 diabetes in advance (as well as
current time diagnosis). They consider claims, pharmacy records, healthcare utilization
and laboratory results of 4.1 million people recorded between 2005 and 2009. The novel
risk factors emerging from their model is studied for different age groups at different stages
before the onset. They achieve an AUC (area under curve) measure of 78 with about 900
3
Diabetes Forecasting
features for prediction of diabetes one year in advance (i.e. with a buffer of one year). They
adopted logistic regression as the machine learning model of choice. Similarly, in an earlier
work (Krishnan et al., 2013) studied the same problem with the same method. For 22
selected features and a complete list of 1054 features, AUCs of 75.2 and 75.6 were achieved,
respectively, also for one year in advance prediction.
A recent study on machine learning-based diabetes prediction is presented in Choi et al.
(2019). A group of 8454 individuals (with no diabetes history) were studied over a period
of 5-year followup. 28 variables were extracted from individual’s electronic medical records
to train a number of models for predicting the occurrence of diabetes within the followup
period (a different problem setup compared to ours). Authors confirmed that the regularized
logistic regression performed the best among their models and results in an AUC of 78.0.
Finally, they performed feature selection based on information gain attribute evaluation. In
fact, their work is one of the few ones that studies features contributions. Similarly to our
findings (using our top model, XGBoost), HbA1c shows up as the most important feature
among theirs. Both their study and ours also give strong importance to glucose values,
while we found age to be of a lesser importance than them.
The study in Nagata et al. (2018) confirms the usefulness of lab test data and health
claim text data including ICD10 codes and pharmacy information. They used three models
for diabetes prediction : L1-regularized logistic regression, XGBoost and a family of LSTM-
based models. Among them, XGBoost provides the best performance with an AUC of 87.0
when using ICD10 and medical text data for predicting diabetes, one year ahead. Note that
we did not use any medical text data in this work due to the very small coverage on our
population with diabetes.
2. Data Cohort
In this section, we describe how our cohort was selected among numerous datasets within
ICES, where some might not be relevant to diabetes prediction.
2.1. Cohort Selection
2.1.1. Diabetes Cohort
The Ontario Diabetes Dataset (ODD) is used to identify individuals with diabetes. The
dataset contains all individuals in the Registered Persons Database (RPDB), who have
been flagged as ones with diabetes based on the algorithm originally introduced by E Hux
et al. (2002). This algorithm flags Physician Service Claims (PSCs) and fee codes and
hospitalizations associated with diabetes based on Hospital Discharge Abstracts (HDAs).
1. ODD would also include the diagnosis date of individuals, which is determined based on
the described algorithm. Details are listed in the supplementary materials. We randomly
selected 10% of people appearing at least once in the ODD.
1. This part was not present in E Hux et al. (2002). In fact, we used the 2016 version of ODD, where the
algorithm is updated to what we described here. The algorithm applies to all individuals in RPDB (even
before 2016)
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2.1.2. Control Cohort
Since our task is a binary prediction, we need to build a negative class of individuals without
diabetes. The control cohort are individuals also selected from the RPDB. It has a similar
number of individuals, who are alive at the time of study and not flagged in ODD. Besides,
the control cohort has the same age and gender distribution as the diabetes cohort.
2.1.3. Exclusion Criteria
The ODD algorithm imposes certain properties for an individual (see supplementary mate-
rials) in how the diagnosis date is determined. It is not surprising that not all individuals
in the ODD would satisfy these properties, as healthcare labels are not perfect. Luckily,
this contributes to a small portion (4.1%) of our diabetes cohort and thus we excluded
these individuals. We also removed the individuals in the control cohort that violate these
properties.
We also scoped down to individuals diagnosed between 2008 to 2017 (both included).
As our task is to forecast diabetes onset, it would be more relevant to focus on more recent
data which are cleaner and contain lab values (OLIS, see Table 1). Lastly, we dropped the
individuals who are younger than 20, mostly corresponding to type I diabetes (Atkinson
et al., 2014; Harjutsalo et al., 2008). Note that our final, adult-only cohort still contains
type I cases, and we predict future incidence of type I and type II combined, The resulting
cohort consists of a total of 146,371 individuals, in which 78,021(53.3%) individuals have
diabetes and 68,350(46.7%) do not.
2.2. Dataset Selection
After constructing the cohort, we first extracted data about each individual from several
sources (eight datasets). These data have no timestamps - we call them fixed features. Then
we selected datasets that are both relevant and useful to our study.
The derived chronic diseases (Asthma, CHF, COPD, HYPER, OCCC, ORAD) consist
of the incidence and prevalence of the chronic disease in each year for each individual. We
kept all the six validated chronic diseases as they are all clinically related to diabetes.
The observations datasets contain more detailed information associated with times-
tamps, and are typically very sparse. Based on the coverage of the diabetes and the con-
trol cohort appearing in the dataset, we selected six observations datasets (OLIS2, DAD,
NACRS, ODB, OHIP and ERCLAIM) in our final data processing setup. They cover lab
values, hospitalizations, ambulance services, and drugs, health and emergency claims. These
datasets and their descriptions are outlined in Table 1 and the coverage of all the datasets
are outlined in the supplementary materials.
2.3. Feature Selection
We manually selected relevant features from each dataset, as required by the data owner.
We dropped features that are 1) missing from the data most of the time; 2) overlapping
with other features; or 3) without a timestamp in the observations dataset 4) occurring
2. OLIS is a relatively new dataset and is being organized and cleaned continuously. Right now, we just
have access to part of OLIS data, most of which are diabetes-related.
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Table 1: Dataset Descriptions
Dataset Full Name #Obs. Available Time Description
OLIS Ontario Laboratories Information System 76,009,197 2006– Lab Values
DAD Discharge Abstract Database 23,699,596 1989– Hospitalization Records
NACRS National Ambulatory Care Reporting System 44,811,484 1999– Ambulatory Records
ODB Ontario Drug Benefit Claims 1,412,758,247 1990– Drugs Claims
OHIP Ontario Health Insurance Plan Claims Database 1,855,101,924 1990– Insurance Claims
ERCLAIM OHIP’s Emergency Claims Database 37,692,110 1991– Emergency Claims
after the prediction date. We then performed feature engineering based on each feature’s
type. Details are in the supplementary materials.
Our model input is built based on a w-year observation window (see Section 3.1). As
multiple observations can occur per year, we aggregated each observation feature within
each year. By default, we averaged observations within each year. We found it useful to
also include the maximum values of observations within each year. We also included in all
cases the number of observations per year per dataset for each individual.
Chronic diseases are recorded yearly hence they do not require aggregation. The date of
each chronic disease in a specific year is set to be January 1st of that year. We concatenated
the aggregated observations and the chronic diseases as temporal vectors. Thus, for each
individual, the feature vector contains a fixed vector portion, and w temporal vectors cor-
responding to each year. We then experimented with concatenating these w yearly vectors,
averaging them, or inputting them in a sequential (temporal) fashion for our LSTMs. See
Figure 1 for illustration. The number of raw features and input features for each dataset is
described in Table 2.
Figure 1: Feature vector for an individual
time
observation window
year 0 year 1 year 2 year 3 year 4 year 5
agg agg agg agg agg
temporal temporal temporal temporal temporal
+
fixed features
or
concat
average
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Table 2: Statistics of the selected datasets. Number of observations refers to the 10-year
window under study (2008-2017) for the final cohort. Raw features correspond to
the number of columns in the used raw database. Input features corresponds to
the features for each year from the dataset fed into the model. The last column
corresponds to the average number of non zero values among yearly feature vectors.
Dataset #Obs #Raw Features #Input Features Avg # non-zero
Fixed Features (RPDB) - 36 240 18.76
Chronic Diseases - 12 12 0.54
OLIS 512,593 6 34 0.65
DAD 446,890 16 305 1.77
NACRS 852,374 12 63 1.19
ODB 13,857,648 4 41 1.08
OHIP 37,701,635 4 153 18.27
ERCLAIM 857,249 6 115 1.85
Total - 96 963 44.11
3. Methods
3.1. Study design
We designed our study to predict the possibility for an individual to have diabetes in the
future. We built the feature vectors from data described above by considering w years
before the current date. We then predicted whether the individuals were to have an onset
of diabetes in b years in the future. To formulate the diabetes prediction problem for the
training data, we set the “current date” to be b years before the prediction date. For
the diabetes cohort, the prediction date is the diagnosis date. For the control cohort, the
prediction date is sampled to match the distribution of the diagnosis dates of the diabetes
cohort (from 2008 to 2017). The design of the prediction task at an individual level is
illustrated in Figure 2. In our study, b = 1, . . . , 10 and w = 1, 3, 5, 10. If the individual does
not have enough history in the observation window, we pad with zeros.
Figure 2: Study design
time
current date prediction dateobservation start date
buffer (b)observation window (w)
3.2. Split
As our main focus is on the clinical application, we used out-of-time test split. As such,
all the individuals with prediction date in 2016 or 2017 were set as test data, while the
ones between 2008 and 2015 (all inclusive) formed the training data. The goal of deploying
our model in production for future diabetes risk screening naturally led to this setup. The
train-test distribution is outlined in Table 3.
7
Diabetes Forecasting
Table 3: Train-Test Split Statistics
Data #Positives #Negatives #Total
Train 67,499 (53.3%) 59,048 (46.7%) 126,547 (86.5%)
Test 10,522 (53.1%) 9,302 (46.9%) 19,824 (13.5%)
Total 78,021 (53.3%) 68,350 (46.7%) 146,371
3.3. Models
As depicted in Figure 1, we have two kinds of final input vectors, avg and concat. While
concat carries temporal information that may be helpful, it also increases the size of the
feature vector w-fold (w is the observation window size). We experimented both types of
input vectors for our study below, except for LSTMs as they are designed to capture the
temporal aspect. Details of these models are described in the supplementary materials.
Logistic Regression We use an L1-regularized logistic regression (LR) model as our
baseline.
XGBoost We use XGBoost, introduced by Chen and Guestrin (2016), as our main model
due to its popularity, high performance and ability to handle missing values well.
Highway Network We also use a relatively simple deep neural network without temporal
aspect called the Highway network (Srivastava et al., 2015). It combines the linear and non-
linear outputs providing greater modeling flexibility for the network compared to the vanilla
multi-layer perceptron (MLP). We found that this network is better than vanilla MLPs in
our application. This neural network has 14,944,001 parameters in the case of avg input
vectors.
CNN-LSTM This model is inspired by the architecture in Tonekaboni et al. (2018) with
a number of changes as follow: We removed the max pooling layers as we found them
damaging the performance. No feature dimensionality reduction was performed in our
setup. We added batch normalization (Ioffe and Szegedy, 2015) after each CNN layer,
which increased the performance and convergence speed simultaneously. Dropout in the
reference architecture was kept in the same place, i.e. after CNN layers. Two layers of
LSTM were used. Finally, we applied a three layer perceptron followed by sigmoid to
perform binary prediction. This model has a total of 22,744,136 parameters.
LSTM-Seq2Seq We borrowed the LSTM-based sequence to sequence architecture from
Sutskever et al. (2014). We used it to reconstruct the concatenation of all (fixed + temporal)
features over time and applied a three layer perceptron on the encoder last hidden layer to
perform the prediction. Hence, this model is data-regularized due to the reconstruction cost
and that makes it different from the CNN-LSTM model. We applied dropout after each
LSTM layer as advised by Zaremba et al. (2014). Teacher forcing (Williams and Zipser,
1989) was also applied to remove the reconstruction drift (bias) and increase the convergence
speed. This model has a total of 32,027,456 parameters.
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4. Results
4.1. Evaluation Approach
We use the area under receive-operation curve (AUC) as our primary metric for model
evaluation. It is a standard metric for binary classification among related literature Choi
et al. (2019); Leong et al. (2018); Razavian et al. (2015b). We also output the usual accuracy,
sensitivity, specificity and positive predictive values for reference. In these cases, we just
use the standard threshold of 0.5.
4.2. Model Performance
Table 4 shows the performance of all models. Note that we experimented with different
values of window size w and buffer size b as well as the corresponding hyperparameters for
training. Detailed results are listed in the supplementary materials.
Table 4: Model performance on test set, for a buffer b = 1 year.
Model AUC Accuracy Sensitivity Specificity PPV
LR - avg 77.7 70.8 67.2 74.8 75.1
LR - concat 78 71.1 68.9 73.4 74.6
XGBoost - avg 79.9 71.9 72.2 71.5 74.1
XGBoost - concat 80.3 72.3 70.5 74.4 75.7
Highway - avg 78.6 71.7 70.3 73.2 74.8
Highway - concat 77.2 69.9 66.8 73.4 74
CNN-LSTM 78 71 77.1 64.1 70.8
LSTM-Seq2Seq 78.4 71.3 72.3 70.1 73.2
weighted average 81.1 72.8 72.2 73.5 75.5
As seen, XGBoost has the best performance among all single models. Moreover, averag-
ing the observations over all years seems to have a similar effect as concatenating them. This
means that the temporal effect is not as useful in the XGBoost model. It is interesting to
notice the disappointing performance of LSTM-based models, comparable to non-temporal
model LR-avg and Highway-avg in this case.
We also show the corresponding AUCs in Figure 3 with different observation window
sizes w for various models and different buffer sizes b for our XGBoost model. Here, we
used both concatenation and averaging aggregation over all years for different window sizes.
It is evident that the larger the observation window, the more accurate the model would
be. But, we observe that for w = 10 in both the XGBoost and Highway models, the model
performs slightly worse than w = 5. This is an indicator that the observation data in the
far past does not contribute much to the prediction performance, possibly due to adding
more noise or mismatching data distributions.
We can also see that the larger the buffer size, the lower the performance of the XGBoost
model, as the task becomes more challenging. It is interesting that even for a buffer of 10
years, the model performance is still better than the models with only fixed features (See
Section 4.5). We see that AUC is maintained above 70 for up to six years ahead prediction.
9
Diabetes Forecasting
Figure 3: Effect of window size w and buffer size b.
1 2 3 4 5 6 7 8 9 10
74
75
76
77
78
79
80
window size w (b = 1)
A
U
C
1 2 3 4 5 6 7 8 9 10
68
69
70
71
72
73
74
75
76
77
78
79
80
buffer size b (w = 5)
LR-avg XGBoost-avg Highway-avg CNN-LSTM
LR-concat XGBoost-concat Highway-concat LSTM-Seq2Seq
4.3. Feature Contribution
For all models, we can compute how much each feature contributes to the results. We use
the additive feature contribution framework. Given a model y = σ(f(X)), and an input
sample x ∈ Rm, where σ is the logistic function and X is the input, the framework will
output the feature contribution φj for feature xj , which satisfies efficiency,∑
j
φj = f(x)− EX(f(X)).
As f(x) is in the logit space, the feature contribution φj can be interpreted as the log
odds ratio between toggling the feature on and off.
Note that as the framework requires an input sample, we aggregate it using the sum of
absolute values to get the feature contribution of each feature across all samples in the test
set. Absolute values are used so that positive and negative effects do not cancel each other
across different samples.3
For LR and XGBoost, we used the Shapley value (Shapley, 1953; Lundberg et al., 2018)
as our feature contributions. For feed-forward neural network models, we used integrated
gradients (Sundararajan et al., 2017) as our feature contributions method, which is an
approximation of the Shapley value (Sundararajan et al., 2017).
Results We listed the top 10 features for logistic regression in Table 5(a). As seen, the
fasting glucose and glucose in serum or plasma are contributing a lot, with an aggregated
Shapley value of about 0.65. We also observe that the geographical region contributes a lot
to our prediction using logistic regression. It’s interesting to note the appearance of landing
3. Note that the aggregated feature contribution values do not tell the correlation between the feature
values with respect to the outcome.
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date here, which takes non-null values only for immigrants as it’s their date of arrival in
Canada.
Table 5: Feature Contributions on test set. Here w = 5 and b = 1.
OLIS Range=Measurement (of any observation code) falls in range; Blood HbA1c=LOINC 4548-4; Fasting
Glucose (in Serum/Plasma)=LOINC 14771.0; Glucose (in Serum/Plasma)=LOINC 14749-6; A1c Mass
Fraction=LOINC 71875-9
Max corresponds to the maximum within the year;
LHIN=Local Health Integration Networks
(a) LR-avg
Feature Contrib.
Fasting Glucose 0.665
Glucose 0.632
Max Blood HbA1c 0.321
LHIN Central 0.302
Landing date 0.277
LHIN Central East 0.258
LHIN Champlain 0.239
LHIN Hamilton Niagara 0.23
LHIN Mississauga Halton 0.214
Max A1c Mass Fraction 0.209
(b) XGBoost-avg
Feature Contrib.
A1c 0.908
OLIS: Range 0.282
Max Blood HbA1c 0.222
Fasting Glucose 0.176
OLIS: Max Range 0.164
Max A1c Mass Fraction 0.154
Asthma: Prevalence 0.141
Max Glucose 0.141
Hypertension OHIP Claim 0.116
Immunity OHIP Claim 0.096
(c) Highway-avg
Feature Contrib.
OLIS: Max Range 1.964
OLIS: Range 1.742
Fasting Glucose 0.407
Glucose 0.375
Longitude 0.351
Max Glucose 0.340
Max Fasting Glucose 0.335
Age 0.310
Birth Year 0.310
Rurality (No) 0.226
The top 10 features for XGBoost are in Table 5(b). As seen, A1c contributes the most
(i.e. an aggregated Shapley value of 0.908), followed by lab values. Prevalence of asthma
in the top 10 corroborates studies stating that the use of steroids in the treatment of
asthma can result in an increase in blood sugar level (Suissa et al., 2010). There is also
correlation between individuals with diabetes having increased risk of getting asthma and
other chronic diseases (Ehrlich et al., 2010). We also see that an OHIP (insurance) claim
for hypertension and immunity appear among the top features, suggesting that they may
be relevant to diabetes onset.
Table 5(c) shows the top 10 features for the Highway model. It is mainly lab values but
it includes a geographical feature (longitude). Note that in the Highway model, age seems
to be more important than the other two models. We can see that the contribution values
are much higher than those of the logistic regression and XGBoost, but this can be shown
in the distribution of the model predictions. (See supplementary materials)
In conclusion, it seems that the glucose and A1c are very important lab results as they
appear in all three models. Geographical feature (LHIN, longitude among others) in logistic
regression and Highway network indicate that the location does affect the probability of
having diabetes based on the data we have (Booth et al., 2012) .
4.4. Evaluation on Different Demographics
As our models are trained on the whole training set, we are interested in discovering how they
would perform on each demographic. We thus report performance and feature contributions
for different demographics. When not specified, the model is XGBoost-avg with w = 5 and
b = 1 as it is our best model with avg and second-best overall. It is only slightly worse than
concat all the years which takes a much longer time and much more resources.
Age, Gender and Country of Origin Table 6 shows the model performances for the
demographic groups gender, age and country of origin. As we can see, our results scale to
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most subcategories, especially when the sample size is high. It is worth noting the decrease
in AUC for people younger than 40.
The feature contributions for each demographic is detailed in the supplementary mate-
rials. It is worth noticing that the prevalence of asthma is relatively more important for
individuals younger than 50. As for country of origin, landing date is an important feature
for people from China. This is in line with Alangh et al. (2013).
Table 6: XGBoost-avg performance on different demographics for w = 5 and b = 1
(a) Age
Age #Test Individuals AUC
20-29 662 73.9
30-39 1808 75.8
40-49 3251 81.6
50-59 5426 81.6
60-69 4673 79.6
70-79 2735 79.1
80-89 1016 76.4
90+ 248 76.8
(b) Gender
Gender #Test Individuals AUC
Male 10565 80
Female 9259 79.7
(c) Country of origin
Country of Origin #Test Individuals AUC
Canada 18144 79.6
India 519 81.9
China 374 84.9
Philippines 353 75.4
Pakistan 233 75
Sri Lanka 201 67.5
4.5. Ablation Study
Datasets We investigated the effect of each dataset in the performance of our model
framework. Table 7 outlines the results. It is clear that OHIP and OLIS contain a lot
of effective features that frequently show up among the top features. It is also worth
noting that combining all datasets still gives much better performance. We outline the
most important features for each dataset in the corresponding table in the supplementary
material.
Table 7: Model performance when we only train on the mentioned datasets. We use
XGBoost-avg here with w = 5 and b = 1
Dataset(s) All Fixed Chronic DAD ERCLAIM NACRS ODB OHIP OLIS
AUC 79.9 62.6 63.1 56.7 57.9 58.6 59.4 69.8 72.6
Top Features Similarly, we perform pruning at the feature level by training the model
only on the top k features. Table 8 summarizes the results. As seen, our top feature A1c
only achieves an AUC of 68.8. On the other hand, using the top 15 features is approximately
as good as using all features, suggesting the possibility of having a decent model by only
using a small subset of features. Our study points out relevant features for further studies
hand-picking input features.
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Table 8: Model performance when we only train on the top k features. We use XGBoost-avg
here with w = 5 and b = 1
Number of top features used 1 5 10 15 963 (All)
AUC 68.8 70.9 76.4 79.1 79.9
5. Discussion
5.1. Technical Significance - Revisited
The examined models, i.e. XGBoost, regularized logistic regression, (Highway) multi layer
perceptron, CNN-LSTM and LSTM Seq2Seq are among the most frequently used models in
the recent literature. XGBoost performs the best among the examined models for diabetes
prediction using an observation window of five years and a buffer of one year (i.e. predicting
one year ahead). This is consistent with other studies using ICD codes (Nagata et al., 2018).
One of the challenges entangled with our cohort is the sparsity of features. For the
raw data, only 44 features out of 963 are non-zero, when averaged over years and patients
(see Table 2). XGBoost has been shown to perform extremely well on tabular and sparse
data (Chen and Guestrin, 2016), particularly compared to deep-learning alternatives as
demonstrated in (Nagata et al., 2018) and our work.
LSTM-Seq2Seq with teaching forcing was found to outperform CNN-LSTM (Tonekaboni
et al., 2018). This is expected as sequence to sequence models benefit from data-based
regularization (Ghasedi Dizaji et al., 2017). However, both our temporal LSTMs do not
improve on the Highway network. This is counter-intuitive as temporal models should
aggregate important information over the input sequence, enriching the pre-classification
states. But recurrent networks are hard to train (Pascanu et al., 2013), and in our case,
it is possible that the aggregation within each year constrained the learning capability of
recurrent neural networks.
5.2. Clinical Relevance - Revisited
As observed, A1c and fasting glucose contribute the most to the prediction of diabetes. It
confirms the common practice that A1c is used in diabetes tests to categorize individuals
into having no diabetes, being pre-diabetic or living with diabetes (NIDDK, 2018).
Our study also finds that the prevalence of asthma will affect the diabetes onset (Suissa
et al., 2010) in Ontario. This could lead to taking further steps for individuals with asthma
on their prescribed steroids as it increases blood sugar, that might eventually result in
weight gain and diabetes diagnosis (Suissa et al., 2010).
Our findings regarding hypertension contribution confirms the corresponding literature
studies (Schutta, 2007; Berraho et al., 2012; Hashemizadeh et al., 2013). Besides, geo-
graphical information plays a role too, recommending targeted interventions in higher risk
areas.
As noted in Alangh et al. (2013), there is an increase in Chinese-Canadian diabetes
incidence between 1996–2005. Landing date is one of the important features we study in
predicting onset of diabetes for Chinese immigrants (or permanent residents). Hence, it is
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worth further research on to figure out the reason behind this fact. We also found that
it is a harder task to predict diabetes on people under 40 years old. It was found that
approximately 80 − 92% of patients with early onset of diabetes are obese compared to
only 56% of older ones Wilmot and Idris (2014). We do not have obesity nor BMI as input
features, which probably makes it harder for our model to capture the specifics of early
diabetes onset.
Our diabetes prediction method can be run without requiring additional data sources, as
it relies on routine health data. It is modular, can be applied to any individual and general-
izes well across all subcategories of gender, age and country of origin. If low computational
resources are imposed, using 15 features would still get a strong AUC.
5.3. Limits
The data that we use has numerous limitations. BMI has been shown to be a key component
of diabetes pre-screening (Edelstein et al. (1997)) but is missing in our datasets. Our study
lacks other important lab values such as cholesterol and glutamate decarboxylase antibodies.
Finally, we only have country of origin as a proxy for ethnicity. All of this affects our model’s
prediction capacity.
5.4. Future Work
Predicting diabetes from self-reported results A similar (yet distinct) task com-
pared to ours is predicting whether an individual will get diabetes in a range of 5−10 years
based on yearly survey data (Rosella et al., 2011). Surveys typically include some more
personal level information such as dietary practice, physical activity, stress level and BMI,
which are absent from the datasets used in this study. It is also possible to propose a model
to make personalized recommendations for individuals at higher risk of diabetes.
Diabetes clustering Diabetes can be roughly classified into 3 different types (Type I,
Type II and gestational diabetes). It is believed that type II is very heterogeneous, and
recent work by Ahlqvist et al. (2018) applied a clustering method using six important
features to cluster a diabetes cohort into five types. We plan to explore different clustering
methods (including the deep learning ones) on our diabetes cohort. A potential clinical
application is that different types can be treated differently, i.e. a major step towards
personalized treatment.
6. Conclusion
In this study, we demonstrated the effectiveness of machine learning algorithms to predict
future onset of diabetes considering an individual’s medical history over the last few years.
Using a single XGBoost model, we reached a test-AUC of 80.3, predicting diabetes one
year ahead, which outperforms any other model we examined. The provided features’
contribution show that lab results (led by A1c) are essential for the task, which advocates
for A1c screening. Other chronic diseases’ flags (such as asthma, hypertension, etc) as well
as diagnosis codes in insurance claims are among the top feature contributors, containing
signals on future diabetes incidence more than five years ahead.
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